Member-only story
The Surging Clot Crisis: What You Need to Know About TRT and the Rise in Blood Clots
Welcome back, health enthusiasts! In recent years, there has been a surge in the utilization of testosterone replacement therapy (TRT) as more men seek to address low testosterone levels. However, this growing trend raises important considerations regarding the potential impact on blood coagulation and the alarming rise in blood clot-related incidents. Today, we delve into the fascinating realm of TRT, its effects on sex hormone-binding globulin (SHBG), and how this interplay can contribute to increased procoagulation and heightened health risks. It’s crucial to stay informed and be aware of these factors as we navigate the realm of hormonal health. Let’s explore the science and connect the dots between TRT, SHBG, and the concerning rise in blood clot incidents.
The Complex Relationship between TRT and SHBG:
Testosterone replacement therapy is known to increase testosterone levels, aiming to restore hormonal balance. As testosterone levels rise, the body responds with a negative feedback mechanism to maintain equilibrium. This feedback loop leads to a decrease in the production of SHBG.
Unraveling the Molecular Pathways:
To comprehend the underlying pathology, we must explore the molecular pathways involved:
